Obrascón Huarte Lain (OHLA) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
22 Jul, 2026Executive summary
Revenue for H1 2025 was €1.69 billion, with EBITDA of €84.1 million, up 46.3% year-over-year and a 5% margin, mainly driven by the Construction division, while Industrial sales dropped 53.3%.
Attributable net loss was €29.7 million, impacted by non-recurring financial expenses and FX losses from recapitalisation and international operations.
New contracts totaled €2.218 billion, book-to-bill ratio was 1.3, and order backlog reached €8.628 billion, up 2% from year-end 2024.
73.9% of revenue was generated abroad, with strategic divestment of the Services business classified as a discontinued operation.
Results align with 2025 guidance, supporting confidence in the operational roadmap.
Financial highlights
EBITDA rose 46.3% to €84.1 million, EBIT improved to €46.2 million, and net loss narrowed to €29.7 million.
Cash position at €663 million, stable year-over-year; total liquidity €663.2 million.
Leverage ratio reduced to 1.8x (recourse), down from 3.0x at Dec 2024 and over 11 four years ago.
Book-to-bill ratio at 1.3; order backlog covers 25 months of sales.
Share price at end-June: €0.3005, down 25.5% YTD; market cap: €415.7 million.
Outlook and guidance
Confident in achieving full-year EBITDA guidance of €175 million, including the services division.
Construction margins and order book expected to remain strong; Industrial division margins and backlog anticipated to improve in H2 2025.
Strategic cost reduction plan targets €40 million in annual savings, aiming to lower cost-to-sales ratio below 3%.
Latest events from Obrascón Huarte Lain
- Record debt reduction, EBITDA growth, and legal clarity set up a strong 2026 outlook.OHLA
Q4 20258 Jul 2026 - EBITDA and net profit surged on margin gains, with a growing order book and strong liquidity.OHLA
Q1 202627 May 2026 - Sales up 21.8% to EUR 1.72B, but net loss and capital increase mark a shift to deleveraging.OHLA
H1 20242 Feb 2026 - Sales up 16%, EBITDA up 11.3%, leverage down, and €150M recapitalization completed.OHLA
Q4 202423 Dec 2025 - EBITDA surged 30% to €113M as recapitalisation and cost controls offset lower sales.OHLA
Q3 20258 Dec 2025 - EBITDA margin improved and leverage reduced, but net loss widened on recapitalization costs.OHLA
Q1 202530 Jun 2025 - Revenue up 17.4% to €2.65bn, but net loss of €58.3m amid recapitalization and asset sales.OHLA
Q3 202413 Jun 2025